Novo Nordisk says it will cut the price of Wegovy. This comes after a similar move by Zepound-maker Eli Lilly.

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

Eli Lilly and Company (NYSE:LLY) and EVA Pharma announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated ...

Eli Lilly and Company (NYSE:LLY) and EVA Pharma announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated 20,000 people in... Tuesday, Eli Lilly ...